MDEV vs. IDNA
MDEV (First Trust Indxx Medical Devices ETF) and IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) are both Health & Biotech Equities funds - MDEV tracks the Indxx Global Medical Equipment Index while IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index. Both are passively managed. Over the past 3 years, MDEV returned -2.86%/yr vs 6.74%/yr for IDNA. A 0.64 correlation means they provide meaningful diversification when combined. MDEV charges 0.70%/yr vs 0.47%/yr for IDNA.
Performance
MDEV vs. IDNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MDEV achieves a -11.48% return, which is significantly lower than IDNA's 10.31% return.
MDEV
- 1D
- 0.04%
- 1M
- 1.54%
- YTD
- -11.48%
- 6M
- -12.29%
- 1Y
- -7.05%
- 3Y*
- -2.86%
- 5Y*
- —
- 10Y*
- —
IDNA
- 1D
- 0.73%
- 1M
- -2.56%
- YTD
- 10.31%
- 6M
- 8.52%
- 1Y
- 40.87%
- 3Y*
- 6.74%
- 5Y*
- -8.42%
- 10Y*
- —
MDEV vs. IDNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
MDEV First Trust Indxx Medical Devices ETF | -11.48% | 2.00% | 1.79% | 7.55% | -28.59% | 4.16% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 10.31% | 17.26% | -0.72% | -7.63% | -42.28% | -10.15% |
Correlation
The correlation between MDEV and IDNA is 0.55, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.55 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.58 |
Correlation (All Time) Calculated using the full available price history since Jun 24, 2021 | 0.64 |
The correlation between MDEV and IDNA has been stable across timeframes, ranging from 0.55 to 0.64 - a consistent structural relationship.
MDEV vs. IDNA - Sectors Allocation Comparison
Sectors
MDEV
IDNA
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
MDEV
IDNA
Basic Materials
MDEV
-
IDNA
-
Communication Services
MDEV
-
IDNA
-
Consumer Cyclical
MDEV
-
IDNA
-
Consumer Defensive
MDEV
-
IDNA
-
Energy
MDEV
-
IDNA
-
Financial Services
MDEV
-
IDNA
-
Industrials
MDEV
-
IDNA
Real Estate
MDEV
-
IDNA
-
Technology
MDEV
-
IDNA
-
Utilities
MDEV
-
IDNA
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MDEV vs. IDNA — Risk / Return Rank
MDEV
IDNA
MDEV vs. IDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Indxx Medical Devices ETF (MDEV) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MDEV | IDNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.12 | ||
| Sortino ratioReturn per unit of downside risk | -2.96 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 1.27 | -0.33 |
| Calmar ratioReturn relative to maximum drawdown | -0.39 | 3.85 | -4.24 |
| Martin ratioReturn relative to average drawdown | -0.98 | 10.98 | -11.96 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MDEV | IDNA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.44 | 1.68 | -2.12 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.30 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.32 | 0.10 | -0.42 |
Drawdowns
MDEV vs. IDNA - Drawdown Comparison
The maximum MDEV drawdown since its inception was -42.34%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for MDEV and IDNA.
Loading charts...
Drawdown Indicators
| MDEV | IDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.34% | -68.26% | +25.92% |
Max Drawdown (1Y)Largest decline over 1 year | -18.13% | -10.66% | -7.47% |
Max Drawdown (3Y)Largest decline over 3 years | -22.50% | -29.73% | +7.23% |
Max Drawdown (5Y)Largest decline over 5 years | — | -68.26% | — |
Current DrawdownCurrent decline from peak | -33.76% | -45.61% | +11.85% |
Average DrawdownAverage peak-to-trough decline | -25.65% | -36.24% | +10.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.22% | 3.73% | +3.49% |
Volatility
MDEV vs. IDNA - Volatility Comparison
The current volatility for First Trust Indxx Medical Devices ETF (MDEV) is 4.60%, while iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a volatility of 7.18%. This indicates that MDEV experiences smaller price fluctuations and is considered to be less risky than IDNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MDEV | IDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.60% | 7.18% | -2.58% |
Volatility (6M)Calculated over the trailing 6-month period | 11.42% | 17.98% | -6.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.00% | 24.48% | -8.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.98% | 28.42% | -9.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.98% | 29.53% | -10.55% |
MDEV vs. IDNA - Expense Ratio Comparison
MDEV has a 0.70% expense ratio, which is higher than IDNA's 0.47% expense ratio.
Dividends
MDEV vs. IDNA - Dividend Comparison
MDEV has not paid dividends to shareholders, while IDNA's dividend yield for the trailing twelve months is around 1.07%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 1.07% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
MDEV First Trust Indxx Medical Devices ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
MDEV and IDNA have a correlation of 0.55, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IDNA has higher volatility (7.18%) compared to MDEV (4.60%). In terms of maximum drawdown, MDEV dropped -42.34% vs IDNA's -68.26%.
On 3-year performance, IDNA leads with 6.74% vs -2.86% for MDEV. On fees, IDNA is cheaper at 0.47% per year. On volatility, MDEV has been the lower-risk option at 4.60%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, IDNA has performed better with a 6.74% return vs -2.86%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IDNA is cheaper with a 0.47% expense ratio, compared with 0.70% for MDEV.
IDNA has the higher dividend yield at 1.07%, compared with 0.00% for MDEV.
MDEV tracks Indxx Global Medical Equipment Index, while IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index. They also come from different issuers: First Trust and iShares. Their fees differ too: 0.70% for MDEV and 0.47% for IDNA.
IDNA currently has the higher Sharpe Ratio (1.68 vs -0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MDEV and IDNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer